ClinConnect ClinConnect Logo
Search / Trial NCT06323096

Development of Clinical Decision Support System for Severe Patients With Polytrauma

Launched by SEMEY STATE MEDICAL UNIVERSITY · Mar 14, 2024

Trial Information

Current as of July 26, 2025

Recruiting

Keywords

Severe Polytrauma Clinical Decision Support System

ClinConnect Summary

This clinical trial is focused on developing a new system that can help doctors make better decisions for patients who have suffered severe injuries from multiple sources, known as polytrauma. The main goal is to see if it’s possible to predict certain serious complications within the first 24 hours of admission to the hospital. These complications include conditions like systemic inflammatory response syndrome (a severe body reaction), significant blood loss, and pneumonia. The study will also look at how well patients are likely to recover.

To participate in this study, individuals must be over 18 years old and provide informed consent. Eligible patients will have specific types of injuries and other health indicators that meet the study’s criteria. Importantly, this study does not involve any treatments or interventions; it will simply observe and collect data to improve future care. If you or a loved one fits the eligibility requirements, you could contribute to important research that aims to enhance the care of severely injured patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Availability of informed consent, signed by the patient or his legal representative;
  • Patients over 18 years of age;
  • * Expanded criteria of the new Berlin definition of polytrauma: patients who comply with three conditions:
  • 1. Presence of damage to one area of the body with an AIS score ≥3 points.
  • 2. Presence of damage to ≥2 areas of the body with an AIS score of ≥2.
  • 3. Presence of ≥1 physiological risk factors and/or primary hospitalization in the ICU.
  • Completeness of the medical record in terms of laboratory and instrumental studies and protocol of therapeutic and surgical treatment.
  • Exclusion Criteria:
  • Refusal to participate in the study at any stage.
  • Death within one hour after hospitalization.
  • Missing data.
  • Patients who seek primary care 24 hours after injury.
  • Patients requiring transfer between profiles and hospitals for implementation of rehabilitation or other stages of therapy.
  • Patients with prematurely interrupted treatment.
  • Trauma combined with suffocation, drowning, frostbite, electrical trauma, or chemical and/or thermal burns.
  • Patients with pathological fractures.
  • Pregnant women.
  • Cases with predominantly severe craniocephalic (GCS \<7 points) or spinal injury (deep paresis and plegias).

About Semey State Medical University

Semey State Medical University is a leading educational and research institution in Kazakhstan, dedicated to advancing healthcare through innovative clinical research and training. With a commitment to improving public health, the university conducts rigorous clinical trials that adhere to international standards and ethical guidelines. By fostering collaboration among researchers, healthcare professionals, and industry partners, Semey State Medical University aims to contribute significantly to the development of new therapeutic interventions and enhance medical knowledge, ultimately improving patient outcomes in the region and beyond.

Locations

Semey, Abai, Kazakhstan

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported